Matsuyama, Yutaka

Publishing since 1984 (Dinosaur)

Has published 104 publications in 27 years

Number of publications published per year by Matsuyama, Yutaka. (Source : PubMed)

Distribution of publications types for Matsuyama, Yutaka. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Takayasu K, Arii S, Ikai I, Kudo M, Matsuyama Y, Kojiro M, Makuuchi M. Overall survival after transarterial lipiodol infusion chemotherapy with or without embolization for unresectable hepatocellular carcinoma: propensity score analysis.  AJR Am J Roentgenol  2010;194;3  
•  Onishi S, Nagashima T, Kimura H, Matsuyama Y, Yoshio T, Minota S. Systemic lupus erythematosus and Sjogren syndrome induced in a case by interferon-{alpha} used for the treatment of hepatitis C.  Lupus  2010  
•  Matsuyama Y. [Role of biological statistics in clinical studies]  Nippon Jibiinkoka Gakkai Kaiho  2010;113;1  
•  Naruse T, Yanase M, Takahashi H, Horie Y, Ito M, Imaizumi T, Oguri K, Matsuyama Y. Prediction of clinical results of laminoplasty for cervical myelopathy focusing on spinal cord motion in intraoperative ultrasonography and postoperative magnetic resonance imaging.  Spine  2009;34;24  
•  Yamamoto K, Imamura H, Matsuyama Y, Hasegawa K, Beck Y, Sugawara Y, Makuuchi M, Kokudo N. Significance of alpha-fetoprotein and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma undergoing hepatectomy.  Annals of surgical oncology  2009;16;10  
•  Ebi H, Sato T, Sugito N, Hosono Y, Yatabe Y, Matsuyama Y, Yamaguchi T, Osada H, Suzuki M, Takahashi T. Counterbalance between RB inactivation and miR-17-92 overexpression in reactive oxygen species and DNA damage induction in lung cancers.  Oncogene  2009;28;38  
•  Ueno H, Kosuge T, Matsuyama Y, Yamamoto J, Nakao A, Egawa S, Doi R, Monden M, Hatori T, Tanaka M, Shimada M, Kanemitsu K. A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer.  Br. J. Cancer  2009;101;6  
•  Sakai Y, Matsuyama Y, Katayama Y, Imagama S, Ito Z, Wakao N, Kanemura T, Yoshida G, Sato K, Ando T, Nakamura H, Kato F, Yukawa Y, Ito K, Ishiguro N. Spinal myxopapillary ependymoma: neurological deterioration in patients treated with surgery.  Spine  2009;34;15  
•  Matsuyama Y, Hayashi T, Terawaki H, Negawa T, Terada T, Okano Y, Era S. Human astrocytes and aortic endothelial cells actively convert the oxidized form of albumin to the reduced form: reduced albumin might participate in redox regulation of nerve and blood vessel systems.  J Physiol Sci  2009;59;3  
•  Rai Y, Sagara Y, Ooi Y, Sagara Y, Sagara Y, Baba S, Tamada S, Matsuyama Y, Ando M. [Preoperative therapy using trastuzumab and weekly paclitaxel in a stage IIIB inoperable locally advanced HER2- positive breast cancer with complete pathologic response]  Gan To Kagaku Ryoho  2009;36;3  

[ See timeline ] [ See all publications ]